null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Innocent Bystanders (Developing Countries and the War on Drugs)

List Price: $52.50
SKU:
9780821380345
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Palgrave Macmillan UK, Philip Keefer, Norman Loayza
    Format:
    Paperback
    Pages:
    388
    Publisher:
    The World Bank (March 24, 2010)
    Language:
    English
    Audience:
    Professional and scholarly
    ISBN-13:
    9780821380345
    ISBN-10:
    0821380346
    Dimensions:
    6" x 9"
    File:
    Eloquence-IPG_03192026_P9854863_onix30_Complete-20260319.xml
    Folder:
    Eloquence
    List Price:
    $52.50
    As low as:
    $49.88
    Publisher Identifier:
    P-IPG
    Discount Code:
    H
    Pub Discount:
    32
    Imprint:
    World Bank Publications
    Weight:
    16oz
  • Overview

    The drug policies of wealthy consuming countries emphasize criminalization, interdiction, and eradication. Such extreme responses to social challenges risk unintended, costly consequences. The evidence presented in this volume is that these consequences are high in the case of current drug policies, particularly for poor transit and producer countries. These costs include the deaths of thousands in the conflict between drug cartels and security forces, political instability, and the infiltration of criminal elements into governments, on the one hand; and increased narcotics use in countries that would not otherwise have been targeted by drug suppliers. Despite such costs, extreme policies could be worthwhile if their benefits were significantly higher than those of more moderate, less costly policies. The authors review the evidence on the benefits of current policies and find that they are clouded in uncertainty: eradication appears to have no permanent effect on supply; the evidence on criminalization does not exclude either the possibility that its effects on drug consumption are low, or that they are high. Uncertainty over benefits and the high costs of current policies relative to alternatives justifies greater emphasis on lower cost policies and more conscientious and better-funded efforts to assess the benefits of all policies.